Story
Celestica Stock Rallies on High Expectations for Q3 Earnings and Investor Day

Celestica Inc. (CLS) shares climbed 2.5% in recent trading as investors anticipated the release of the company's third-quarter 2026 earnings report and its Investor and Analyst Day, both scheduled for after the market close.
Analyst Bullishness and Earnings Expectations
Market sentiment is buoyed by high expectations, with analysts forecasting significant year-over-year growth. The consensus estimate is for quarterly earnings of approximately $2.97 per share on revenue of about $5.47 billion, a substantial increase from the $1.58 per share reported in the same period a year ago. Celestica enters the report with a strong track record, having surpassed consensus earnings per share (EPS) estimates in each of the last eight quarters.
Several Wall Street analysts have raised their price targets on the stock ahead of the announcement:
- JPMorgan analyst Joseph Cardoso maintained an Overweight rating and increased his price target to $485 from $445.
- Wolfe Research analyst George Notter maintained an Outperform rating while raising his target to $475 from $425.
AdThis reflects a broadly positive view, with the stock holding a "Moderate Buy" consensus rating from analysts, according to Investing.com.
Market Context and Key Investor Questions
The rally is supported by a constructive backdrop in the broader market, with the S&P 500 and Nasdaq indices both advancing. This has lifted sentiment across the technology sector, particularly for companies involved in artificial intelligence infrastructure.
For investors, the key focus will be on the company's ability to sustain its growth trajectory. The report and subsequent analyst day are expected to provide clarity on whether rapid expansion in 800G and 1.6T networking programs can continue to drive results, while also addressing concerns about customer concentration and rising capital requirements.
Read next
More on Stocks
NVIDIA Stock Rallies on Strong AI Demand Signals from SpaceX, Morgan Stanley
Shares of the chipmaker gained over 3% following reports of a $40 billion GPU procurement plan by SpaceX and a bullish note from Morgan Stanley highlighting increased data center demand.

Nanobiotix Shares Rise on Positive Phase 1 Melanoma Trial Data
Nanobiotix (NASDAQ: NBTX) stock gained after the company reported promising final data from a Phase 1 trial of its cancer therapy, JNJ-1900, which showed a 41.7% overall response rate in patients with advanced, treatment-resistant melanoma.

Moroccan All Shares Index Edges Up 0.14% on Sector Strength
The Casablanca stock market closed slightly higher on Monday, with the benchmark Moroccan All Shares index gaining 0.14% amid strength in the banking and beverage sectors, despite a majority of stocks declining.

Petrobras CEO Dismisses Post-Election Stock Plunge as 'Speculative'
Petrobras CEO Magda Chambriard labeled the nearly 10% drop in the company's shares following President Lula's reelection as a 'speculative move,' asserting the state-run oil firm's fundamentals remain strong.